View in EDS HTML Full Text PDF Full Text

Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.

Saved in:
Bibliographic Details
Title: Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
Authors: Lucas DM; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Ruppert AS; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Lozanski G; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Dewald GW; b Mayo Clinic , Rochester , MN , USA., Lozanski A; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Claus R; c University of Freiburg Medical Center , Freiburg , Germany.; d German Cancer Research Center , Heidelberg , Germany., Plass C; d German Cancer Research Center , Heidelberg , Germany., Flinn IW; e Sarah Cannon Research Institute and Tennessee Oncology , Nashville , TN , USA., Neuberg DS; f Dana Farber Cancer Institute , Boston , MA , USA., Paietta EM; g Montefiore Medical Center , Bronx , NY , USA., Bennett JM; h University of Rochester , Rochester , NY , USA., Jelinek DF; b Mayo Clinic , Rochester , MN , USA., Gribben JG; i Barts Cancer Institute, Queen Mary University of London , London , UK., Hussein MA; j Celgene Corporation , Summit , NJ , USA., Appelbaum FR; k Fred Hutchinson Cancer Research Center , Seattle , WA , USA., Larson RA; l University of Chicago , Chicago , IL , USA., Moore DF Jr; m Cancer Center of Kansas , Wichita , KS , USA., Tallman MS; n Memorial Sloan Kettering Cancer Center , New York , NY , USA., Byrd JC; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Grever MR; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2015; Vol. 56 (11), pp. 3031-7. Date of Electronic Publication: 2015 Mar 30.
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25721902
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lucas+DM%22">Lucas DM</searchLink>; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.<br /><searchLink fieldCode="AU" term="%22Ruppert+AS%22">Ruppert AS</searchLink>; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.<br /><searchLink fieldCode="AU" term="%22Lozanski+G%22">Lozanski G</searchLink>; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.<br /><searchLink fieldCode="AU" term="%22Dewald+GW%22">Dewald GW</searchLink>; b Mayo Clinic , Rochester , MN , USA.<br /><searchLink fieldCode="AU" term="%22Lozanski+A%22">Lozanski A</searchLink>; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.<br /><searchLink fieldCode="AU" term="%22Claus+R%22">Claus R</searchLink>; c University of Freiburg Medical Center , Freiburg , Germany.; d German Cancer Research Center , Heidelberg , Germany.<br /><searchLink fieldCode="AU" term="%22Plass+C%22">Plass C</searchLink>; d German Cancer Research Center , Heidelberg , Germany.<br /><searchLink fieldCode="AU" term="%22Flinn+IW%22">Flinn IW</searchLink>; e Sarah Cannon Research Institute and Tennessee Oncology , Nashville , TN , USA.<br /><searchLink fieldCode="AU" term="%22Neuberg+DS%22">Neuberg DS</searchLink>; f Dana Farber Cancer Institute , Boston , MA , USA.<br /><searchLink fieldCode="AU" term="%22Paietta+EM%22">Paietta EM</searchLink>; g Montefiore Medical Center , Bronx , NY , USA.<br /><searchLink fieldCode="AU" term="%22Bennett+JM%22">Bennett JM</searchLink>; h University of Rochester , Rochester , NY , USA.<br /><searchLink fieldCode="AU" term="%22Jelinek+DF%22">Jelinek DF</searchLink>; b Mayo Clinic , Rochester , MN , USA.<br /><searchLink fieldCode="AU" term="%22Gribben+JG%22">Gribben JG</searchLink>; i Barts Cancer Institute, Queen Mary University of London , London , UK.<br /><searchLink fieldCode="AU" term="%22Hussein+MA%22">Hussein MA</searchLink>; j Celgene Corporation , Summit , NJ , USA.<br /><searchLink fieldCode="AU" term="%22Appelbaum+FR%22">Appelbaum FR</searchLink>; k Fred Hutchinson Cancer Research Center , Seattle , WA , USA.<br /><searchLink fieldCode="AU" term="%22Larson+RA%22">Larson RA</searchLink>; l University of Chicago , Chicago , IL , USA.<br /><searchLink fieldCode="AU" term="%22Moore+DF+Jr%22">Moore DF Jr</searchLink>; m Cancer Center of Kansas , Wichita , KS , USA.<br /><searchLink fieldCode="AU" term="%22Tallman+MS%22">Tallman MS</searchLink>; n Memorial Sloan Kettering Cancer Center , New York , NY , USA.<br /><searchLink fieldCode="AU" term="%22Byrd+JC%22">Byrd JC</searchLink>; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.<br /><searchLink fieldCode="AU" term="%22Grever+MR%22">Grever MR</searchLink>; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2015; Vol. 56 (11), pp. 3031-7. <i>Date of Electronic Publication: </i>2015 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25721902
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3109/10428194.2015.1023800
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3031
    Titles:
      – TitleFull: Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lucas DM
      – PersonEntity:
          Name:
            NameFull: Ruppert AS
      – PersonEntity:
          Name:
            NameFull: Lozanski G
      – PersonEntity:
          Name:
            NameFull: Dewald GW
      – PersonEntity:
          Name:
            NameFull: Lozanski A
      – PersonEntity:
          Name:
            NameFull: Claus R
      – PersonEntity:
          Name:
            NameFull: Plass C
      – PersonEntity:
          Name:
            NameFull: Flinn IW
      – PersonEntity:
          Name:
            NameFull: Neuberg DS
      – PersonEntity:
          Name:
            NameFull: Paietta EM
      – PersonEntity:
          Name:
            NameFull: Bennett JM
      – PersonEntity:
          Name:
            NameFull: Jelinek DF
      – PersonEntity:
          Name:
            NameFull: Gribben JG
      – PersonEntity:
          Name:
            NameFull: Hussein MA
      – PersonEntity:
          Name:
            NameFull: Appelbaum FR
      – PersonEntity:
          Name:
            NameFull: Larson RA
      – PersonEntity:
          Name:
            NameFull: Moore DF Jr
      – PersonEntity:
          Name:
            NameFull: Tallman MS
      – PersonEntity:
          Name:
            NameFull: Byrd JC
      – PersonEntity:
          Name:
            NameFull: Grever MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2015
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 56
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1